eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
1/2021
vol. 37
 
Share:
Share:
more
 
 
abstract:
Review paper

Two in one: simultaneous use of two long-acting antipsychotics in schizophrenia

Marek Jarema
1

1.
3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (1), 45–51
Online publish date: 2021/11/17
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Objectives
This paper aims to review the literature regarding the possible simultaneous use of two long-acting antipsychotics in the treatment of schizophrenia.

Selected literature review
Despite using the appropriate dose in antipsychotic treatment and continuing it for the necessary period, it happens that such treatment may be considered ineffective. In such a case, to supplement the clinical effect of antipsychotics, the addition of a second antipsychotic medication, mood stabiliser, or an antidepressant may be considered. If the inadequate response to the treatment results from poor medication adherence, the use of long-acting antipsychotic is re­commended. Some clinicians, however, try to use two long-acting antipsychotics simultaneously.

Conclusions
Sparse available data did not allow us to conclude that the simultaneous use of two long-acting antipsychotic agents significantly improves the outcome of pharmacological treatment of schizophrenia.

keywords:

schizophrenia, pharmacological treatment, long-acting antipsychotics

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.